Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT01515215 Completed - Clinical trials for Major Depressive Disorder

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depressive Disorder

Start date: July 2008
Phase: N/A
Study type: Interventional

Major Depressive Disorder (MDD) is one of the most prevalent mental illnesses in North America, in which 30% - 40% fail to respond to conventional treatment. Repetitive Transcranial Magnetic Stimulation (rTMS) has been shown to be an effective therapeutic tool for the treatment of MDD. This form of treatment involves a series of magnetic pulses directed to the brain for about 30 minutes. Importantly, such treatment is very safe and well tolerated. However, to date, most treatment studies show modest efficacy due to limitations, including: 1) treatments that are delivered to only one side of the brain; 2) treatment that does not directly target a specific brain region associated with depression; 3) treatments that are of short duration; 4) treatments that are of insufficient intensity; and 5) insufficient understanding of the brain mechanisms responsible for therapeutic effect. This study is designed to directly address all of these limitations, as well as explore brain mechanisms (e.g. cortical excitability) through which treatment is optimized.

NCT ID: NCT01507948 Completed - Clinical trials for Posttraumatic Stress Disorder (PTSD)

Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)

Start date: September 2010
Phase: N/A
Study type: Interventional

The investigators are seeking people who have been exposed to a traumatic event in the past and have symptoms of posttraumatic stress disorder (PTSD) currently. A person with PTSD may feel significant distress when reminded of a traumatic event or feel depressed, anxious or jumpy. As a part of this study, participants will receive brain MRIs and office assessments before and after psychotherapy. The investigators provide the gold-standard psychotherapy for PTSD, "Prolonged Exposure", free of charge; additionally participants are compensated for their time during assessment procedures. This study is exploring the brain circuitry involved in improvement in response to psychotherapy.

NCT ID: NCT01506232 Terminated - Bipolar Disorder Clinical Trials

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study

Start date: March 2011
Phase:
Study type: Observational

The study aims to evaluate whether or not an EEG (a type of brain scan) is useful in diagnosing youth with either ADHD, BPD, ASD. Youth with ADHD, BPD, ASD, and healthy controls (without ADHD, BPD, and ASD) will undergo an EEG, and the results will be analyzed using brain activity flow pattern analysis (BAFPA). Twenty subjects with each disorder and twenty without any of the disorders under study (controls) will be evaluated. All subjects will be comprehensively assessed with structured diagnostic interviews and neuropsychological testing. All EEG analyses will be conducted under blind conditions. Conditional probability and receiver operating characteristic (ROC) analyses will examine the diagnostic utility of the EEG scan, using the clinical diagnosis of ASD as the gold standard.

NCT ID: NCT01504659 Terminated - Bipolar Disorder Clinical Trials

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

IKBP
Start date: July 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators plan to evaluate the efficacy and safety of intranasal Ketalar (ketamine hydrochloride) in the treatment of primary symptom manifestations of pediatric bipolar disorder; Fear of Harm (FOH) phenotype. This phenotype represents those children who are most resistant to traditional treatments and suffer repeated hospitalizations. Primary symptoms include fearfulness, aggression secondary to threat, mood and/or arousal instability, and psychosis. In addition to evaluation of efficacy and safety, the investigators will also analyze whether therapeutic response depends upon the degree to which the subject fits the FOH phenotype.

NCT ID: NCT01501812 Recruiting - Bipolar Disorder Clinical Trials

Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders

Start date: March 2011
Phase: N/A
Study type: Observational

Learning includes the ability to generalize to new situations and respond to similar, yet not identical stimuli. In previous work, focused on stimulus generalization in healthy volunteers, tones that were negatively reinforced induce wider generalization curves than tones that were positively reinforced, and these in turn induce wider curves than neutral memory (Schechtman et al, 2010). The current study aimed to evaluate those patterns in different clinical disorders (including Schizophrenia, Bipolar disorder, MDD, Anxiety disorders (Panic and GAD) and PTSD, and healthy subjects that would be used as a control), with consideration whether those patterns are unique to any specific disorder or state. The generalization patterns evaluation would conduct twice though enable to compare the stability of those patterns during the course of the illness (i.e during remission compared to acute state). The basic paradigm based on conditioning of a tone (sound) with unpleasant noise, and extinction of that conditioning afterword. During the 60 minutes of evaluation, the capability to discriminate between the original tone and similar but not identical tones, and the tendency to categorize similar tones as identical to the original tone. A neutral tone without conditioning will be used as reference. The clinical diagnosis will conduct by a senior psychiatrist, and the state would be evaluated using standard questionnaires

NCT ID: NCT01501695 Completed - Tourette Syndrome Clinical Trials

Phase III Study of 5LGr to Treat Tic Disorder

5LGr
Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effective and safety of 5LGr in pediatric patients with tic disorders.

NCT ID: NCT01500200 Completed - Clinical trials for Major Depressive Disorder

A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)

Start date: December 2011
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy of ALKS 5461 when administered daily for 4 weeks to adults with Major Depressive Disorder (MDD) and inadequate response to antidepressant therapy.

NCT ID: NCT01494831 Completed - Depression Clinical Trials

Randomized Control Trial of Group Intervention With Former War-affected Boys in the Democratic Republic of Congo

Start date: May 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate, in a randomised control trial (RCT), the effectiveness of group-based, trauma-focused Cognitive Behaviour Therapy (TF-CBT) in reducing psychological distress in former child soldiers and other war-affected children in the Democratic Republic of Congo (DRC).

NCT ID: NCT01492699 Completed - Clinical trials for Post Traumatic Stress Disorder

Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder

Start date: June 2012
Phase: N/A
Study type: Interventional

This is a clinical study for adult subjects with Post Traumatic Stress Disorder.

NCT ID: NCT01491932 Completed - Parkinson Disease Clinical Trials

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Start date: March 2012
Phase: Phase 2
Study type: Interventional

This study is to evaluate long-term safety, tolerability and efficacy for AFQ056 in patients who have completed an AFQ056A study in Parkinson's disease L-dopa induced dyskinesias (PD-LID).